US 12,064,389 B2
Method for improving kidney function with extracorporeal shockwaves
Avner Spector, Savyon (IL)
Filed by Avner Spector, Savyon (IL)
Filed on Nov. 2, 2022, as Appl. No. 18/051,990.
Application 18/051,990 is a continuation of application No. 16/776,901, filed on Jan. 30, 2020, granted, now 11,517,499.
Application 16/776,901 is a continuation of application No. 15/452,568, filed on Mar. 7, 2017, granted, now 10,583,069, issued on Mar. 10, 2020.
Application 15/452,568 is a continuation of application No. 13/359,538, filed on Jan. 27, 2012, abandoned.
Prior Publication US 2023/0285226 A1, Sep. 14, 2023
Int. Cl. A61H 23/00 (2006.01); A61B 17/22 (2006.01); A61B 17/225 (2006.01); A61H 23/02 (2006.01); A61N 7/02 (2006.01); A61B 18/00 (2006.01)
CPC A61H 23/008 (2013.01) [A61B 17/225 (2013.01); A61B 17/2251 (2013.01); A61H 23/02 (2013.01); A61N 7/02 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01)] 3 Claims
OG exemplary drawing
 
1. A non-invasive method for treating chronic kidney disease (CKD) at any stage selected from CKD stage 1 to CKD stage 4, the method provided in the form of non-invasive focused extracorporeal shockwave therapy (‘ESWT’), the method comprising applying between 1 and 2400 focused shockwaves having a repetition rate above one shockwave per second, and energy density of about 0.02 to 0.18 millijoule per millimeter squared (mJ/mm2), applied to at least one treatment zone comprising: nephron, glomerulus, Bowman's capsule, tubules, medulla, renal artery, renal vein, renal pelvis, papilla, adrenal glands, adrenal cortex, adrenal medulla, phrenic arteries, and adrenal vein, neural tissue directly or indirectly innervating a kidney and renal structures, kidney neural system including renal sympathetic and renal para-sympathetic nerves, and renal sympathetic nerves that lie within and immediately adjacent a wall of a renal artery, or any combination thereof;
using an imaging device to aid in defining the at least one treatment zone, wherein the at least one treatment zone is provided with at least 100 shockwaves; and,
wherein the shockwaves are delivered to the at least one treatment zones during at least one session per week for up to about 20 sessions within a time frame of up to about 18 weeks.